Related Experiment Video
Updated: Jun 25, 2026
06:23
Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Current technological advances of bipolar coagulation.
Ananth K Vellimana1, Daniel M Sciubba, Joseph C Noggle
1Department of Neurological Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Neurosurgery
|February 26, 2009
Summary
Electrosurgery, particularly bipolar coagulation, has advanced significantly, offering improved intraoperative bleeding control with less tissue damage. Modern electrosurgical devices enhance surgical precision and patient outcomes.
Area of Science:
- Surgical Technology
- Medical Devices
- Hemostasis
Background:
- Historical use of heat for hemostasis dates back millennia.
- Electrosurgery emerged in the 1920s for surgical hemorrhage control.
- Modern electrosurgery encompasses diverse bipolar coagulation instruments.
Observation:
- Electrosurgery now features highly accurate devices using nonstick and noncontact thermal energy delivery.
- Coagulation instruments have expanded capabilities with irrigating pathways and varied instrument tips.
- Bipolar technology is integrated into microforceps and microscissors for minimally invasive surgery.
Findings:
- Significant advancements in electrosurgical devices and techniques, especially bipolar coagulation.
- New technologies enable precise intraoperative coagulation control.
- Minimized iatrogenic damage from reduced heat spread and tissue adherence.
Implications:
- Potential for improved patient outcomes in neurosurgical procedures.
- Enhanced hemostasis and reduced complications in surgery.
- Bipolar electrosurgery represents a key evolution in surgical bleeding control.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:22Bipolar Junction Transistor
Bipolar Junction Transistors (BJTs) are essential elements in electronic circuits, playing a crucial role in the functionality of amplifiers, memories, and microprocessors. These transistors can be designed as NPN or PNP based on their doping patterns. They consist of three layers: the emitter, base, and collector. The configuration of these layers and their respective doping levels—with N-type or P-type impurities—define the transistor's type and its operational characteristics.
The structure...
The structure...